Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
9.13
+0.04 (0.44%)
Apr 8, 2026, 10:07 AM EDT - Market open
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $484 million as of April 8, 2026. Its market cap has increased by 877.51% in one year.
Market Cap
484.00M
Enterprise Value
382.54M
1-Year Change
877.51%
Ranking
Category
Stock Price
$9.13
Market Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has increased from $65.74M to $484.00M, an increase of 636.19%. That is a compound annual growth rate of 58.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 481.45M | 74.69% |
| Dec 31, 2025 | 275.60M | 355.41% |
| Dec 31, 2024 | 60.52M | -55.98% |
| Dec 29, 2023 | 137.48M | 331.07% |
| Dec 30, 2022 | 31.89M | -32.18% |
| Dec 31, 2021 | 47.02M | -28.48% |
| Dec 16, 2021 | 65.74M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| enGene Holdings | 485.00M |
| Verastem | 481.34M |
| Atea Pharmaceuticals | 467.68M |
| ADC Therapeutics | 466.25M |
| Assembly Biosciences | 465.25M |
| REGENXBIO | 454.19M |
| Absci | 452.94M |
| Eupraxia Pharmaceuticals | 437.01M |